Long-term outcome after arthroscopic debridement of Palmer type 2C central degenerative lesions of the triangular fibrocartilage complex

Arch Orthop Trauma Surg. 2021 Oct;141(10):1807-1814. doi: 10.1007/s00402-021-03918-9. Epub 2021 May 1.

Abstract

Purpose: The purpose of this study was to report long-term objective and patient-reported outcome after arthroscopic debridement of central degenerative triangular fibrocartilage complex (TFCC) lesions.

Methods: A total of 17 patients with central degenerative TFCC (Palmer type 2C) lesions and ulnar positive variance who were treated by arthroscopic debridement were retrospectively reviewed. Mean follow-up was 8.8 years. Assessment facilitating the Modified Mayo Wrist score (MMWS), the Disabilities of the Arm, Shoulder, and Hand questionnaire (DASH score), recording of pain level and of patient satisfaction, and radiological examination were done.

Results: Patients reached a pain level of 1.7 VAS, MMW score of 92, and DASH score of 22. No significant differences could be detected between the operated and the contralateral extremity regarding range of motion and grip strength for all patients. No perioperative complications occurred.

Conclusion: Arthroscopic debridement of central degenerative TFCC lesions is safe, reliable, and efficacious even for ulnar positive variance.

Level of evidence: Therapeutic IV.

Keywords: Arthroscopy; Debridement; TFCC 2C lesions; Ulnar positive variance.

MeSH terms

  • Arthroscopy
  • Debridement
  • Humans
  • Range of Motion, Articular
  • Retrospective Studies
  • Treatment Outcome
  • Triangular Fibrocartilage* / surgery
  • Wrist Injuries*
  • Wrist Joint